Exicure Inc
XCUR4.030USD
-0.230-5.40%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
25.69MMarket Cap
LossP/E TTM
More Details of Exicure Inc Company
Exicure, Inc. is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The Company, through GPCR Therapeutics USA Inc. (GPCR USA), is focused on developing and commercializing an intellectual property and patents related to G-Protein Coupled Receptors. GPCR USA is conducting a Phase II clinical trial for a blood cancer treatment involving GPC-100 (Burixafor). The Company is also exploring strategic alternatives to maximize stockholder value.
Exicure Inc Info
Ticker SymbolXCUR
Company nameExicure Inc
IPO dateMay 09, 2018
CEOYoo (Andy)
Number of employees7
Security typeOrdinary Share
Fiscal year-endMay 09
Address2430 N. Halsted St.
CityCHICAGO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code60614
Phone18476731707
Websitehttps://www.exicuretx.com/
Ticker SymbolXCUR
IPO dateMay 09, 2018
CEOYoo (Andy)
Company Executives of Exicure Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Dongho Lee
Mr. Dongho Lee
Independent Director
Independent Director
--
--
Mr. Andy Yoo
Mr. Andy Yoo
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Seung Ik Baik
Mr. Seung Ik Baik
Chief Financial Officer, Secretary, Director
Chief Financial Officer, Secretary, Director
--
--
Mr. Sangjn Yeo
Mr. Sangjn Yeo
Independent Director
Independent Director
--
--
Ms. Aejin Hwang
Ms. Aejin Hwang
Independent Director
Independent Director
--
--
Dr. Josephine (Pina) Cardarelli, Ph.D.
Dr. Josephine (Pina) Cardarelli, Ph.D.
President, Chief Scientific Officer
President, Chief Scientific Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Dongho Lee
Mr. Dongho Lee
Independent Director
Independent Director
--
--
Mr. Andy Yoo
Mr. Andy Yoo
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Seung Ik Baik
Mr. Seung Ik Baik
Chief Financial Officer, Secretary, Director
Chief Financial Officer, Secretary, Director
--
--
Mr. Sangjn Yeo
Mr. Sangjn Yeo
Independent Director
Independent Director
--
--
Ms. Aejin Hwang
Ms. Aejin Hwang
Independent Director
Independent Director
--
--
Dr. Josephine (Pina) Cardarelli, Ph.D.
Dr. Josephine (Pina) Cardarelli, Ph.D.
President, Chief Scientific Officer
President, Chief Scientific Officer
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Tue, Jan 27
Updated: Tue, Jan 27
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Exicure Hitron Inc. Employees
25.09%
DGP Co., Ltd.
7.73%
Abingworth Management Limited
4.42%
CBI USA, Inc.
2.57%
The Vanguard Group, Inc.
0.66%
Other
59.54%
Shareholders
Shareholders
Proportion
Exicure Hitron Inc. Employees
25.09%
DGP Co., Ltd.
7.73%
Abingworth Management Limited
4.42%
CBI USA, Inc.
2.57%
The Vanguard Group, Inc.
0.66%
Other
59.54%
Shareholder Types
Shareholders
Proportion
Corporation
35.38%
Venture Capital
4.42%
Investment Advisor
0.77%
Investment Advisor/Hedge Fund
0.46%
Hedge Fund
0.03%
Research Firm
0.03%
Other
58.90%
Institutional Shareholding
Updated: Wed, Jan 21
Updated: Wed, Jan 21
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q4
20
392.11K
12.77%
--
2025Q4
31
364.43K
5.72%
-496.82K
2025Q3
34
828.16K
12.99%
+419.96K
2025Q2
39
5.19M
82.14%
+459.49K
2025Q1
39
5.11M
80.94%
+626.75K
2024Q4
39
2.19M
79.53%
+1.26M
2024Q3
38
1.16M
47.48%
+231.16K
2024Q2
41
935.92K
56.32%
-7.21K
2024Q1
63
954.65K
57.41%
-102.69K
2023Q4
69
1.01M
60.85%
-61.54K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Exicure Hitron Inc. Employees
3.33M
52.3%
--
--
Sep 18, 2025
DGP Co., Ltd.
492.61K
7.73%
--
--
Sep 09, 2025
Abingworth Management Limited
281.64K
4.42%
--
--
Sep 30, 2025
CBI USA, Inc.
163.66K
2.57%
--
--
Sep 12, 2024
The Vanguard Group, Inc.
42.04K
0.66%
+14.21K
+51.03%
Sep 30, 2025
Geode Capital Management, L.L.C.
29.32K
0.46%
+10.36K
+54.63%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
5.45K
0.09%
+2.79K
+105.20%
Sep 30, 2025
Tower Research Capital LLC
2.03K
0.03%
+1.06K
+108.41%
Sep 30, 2025
Morgan Stanley & Co. LLC
1.90K
0.03%
+1.44K
+317.84%
Sep 30, 2025
UBS Financial Services, Inc.
18.70K
0.29%
-7.57K
-28.80%
Sep 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Micro-Cap ETF
Proportion0%
iShares Core S&P Total U.S. Stock Market ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
Aug 26, 2024
Merger
5→1
Aug 26, 2024
Merger
5→1
Aug 26, 2024
Merger
5→1
Aug 26, 2024
Merger
5→1
Jun 29, 2022
Merger
30→1
Jun 29, 2022
Merger
30→1
Date
Ex-dividend Date
Type
Ratio
Aug 26, 2024
Merger
5→1
Aug 26, 2024
Merger
5→1
Aug 26, 2024
Merger
5→1
Aug 26, 2024
Merger
5→1
Jun 29, 2022
Merger
30→1
Jun 29, 2022
Merger
30→1
Jun 29, 2022
Merger
30→1
Jun 29, 2022
Merger
30→1
